asia pacific tissue processing systems Market

The Asia Pacific tissue processing systems market is expected to reach US$ 76.29 million by 2027 from US$ 49.58 million in 2019; it is estimated to grow at a CAGR of 5.7% from 2020 to 2027.

The market growth is mainly attributed to the rising prevalence of cancer and increasing number of diagnostic laboratories in Asia Pacific region. However, the high cost of cancer diagnostics restricts the market growth.

Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. According to the estimates of one of the research studies published in the Chinese Journal of Cancer Research, cancer caused ~2,865,174 deaths in 2018, and the death cases included 1,791,805 males and 1,073,369 females. Thus, the increasing prevalence of cancer is likely to boost the demand for tissue processors in cancer diagnosis in the coming years. Also, the growing network of diagnostic laboratories across Asia Pacific region is favoring the growth of the market in this region.

The COVID-19 pandemic situation has a minor impact on the tissue processing systems market in the Asia Pacific region. Restrictions on cross-border trade in several countries worldwide have played an imperative role in disrupting the supply and demand across the tissue processing sector. However, in the long run, the Asia Pacific market is expected to grow at a steady rate, owing to the precautions taken during the tissue processing system.

The Asia Pacific tissue processing systems market, by product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, and the tissue transfer processors segment is expected to register the highest CAGR in the market during the forecast period.

The Asia Pacific tissue processing systems market, based on volume, is segmented into small volume processors, medium volume processors, and large volume processors. The small volume processors segment held the largest share of the market in 2019, and the medium volume processors segment is estimated to register the highest CAGR in the market during the forecast period.

On the basis of end user, the Asia Pacific tissue processing systems market is segmented into hospitals, pharmaceutical companies, research laboratories, and others. The hospitals segment held the largest share of the market in 2019, and the pharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources associated with this report on the Asia Pacific tissue processing systems market are the World Health Organization (WHO), Chinese Journal of Cancer Research (CJCR), and Joint Research Centre (JRC).